- Home
- LGND vs PCH Comparison
LGND vs PCH Comparison
Compare LGND & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- PCH
- Stock Information
- Founded
- LGND 1987
- PCH 1903
- Country
- LGND United States
- PCH United States
- Employees
- LGND 68
- PCH N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- PCH Real Estate Investment Trusts
- Sector
- LGND Health Care
- PCH Real Estate
- Exchange
- LGND Nasdaq
- PCH Nasdaq
- Market Cap
- LGND 3.2B
- PCH 3.3B
- IPO Year
- LGND 1992
- PCH N/A
- Fundamental
- Price
- LGND $184.44
- PCH $40.34
- Analyst Decision
- LGND Strong Buy
- PCH Buy
- Analyst Count
- LGND 8
- PCH 6
- Target Price
- LGND $144.71
- PCH $49.17
- AVG Volume (30 Days)
- LGND 139.7K
- PCH 720.0K
- Earning Date
- LGND 08-05-2025
- PCH 11-03-2025
- Dividend Yield
- LGND N/A
- PCH 4.43%
- EPS Growth
- LGND N/A
- PCH 15.06
- EPS
- LGND N/A
- PCH 0.53
- Revenue
- LGND $181,488,000.00
- PCH $1,056,523,000.00
- Revenue This Year
- LGND $18.41
- PCH $3.29
- Revenue Next Year
- LGND $18.87
- PCH $3.56
- P/E Ratio
- LGND N/A
- PCH $76.76
- Revenue Growth
- LGND 53.40
- PCH N/A
- 52 Week Low
- LGND $81.74
- PCH $36.82
- 52 Week High
- LGND $129.90
- PCH $48.12
- Technical
- Relative Strength Index (RSI)
- LGND 58.00
- PCH 41.10
- Support Level
- LGND $182.87
- PCH $41.69
- Resistance Level
- LGND $194.44
- PCH $43.08
- Average True Range (ATR)
- LGND 5.35
- PCH 1.15
- MACD
- LGND -0.77
- PCH -0.16
- Stochastic Oscillator
- LGND 40.05
- PCH 0.00
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About PCH PotlatchDeltic Corporation
PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.